Larissa Rakhilina

Statistics

Publications

Citations

H-Index

Active since

1998

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Larissa Rakhilina is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, medicinal chemistry, and molecular biology.

ORCID

Publications per year

1998–2020

Publications

An orally available non-nucleotide STING agonist with antitumor activity

Bo‐Sheng Pan, Samanthi A. Perera, Jennifer Piesvaux et al. · Science · 2020 · 660 citations

Medicine, Medicinal Chemistry, Pharmacology +16

Degradation Signal Masking by Heterodimerization of MATα2 and MATa1 Blocks Their Mutual Destruction by the Ubiquitin-Proteasome Pathway

Phoebe Johnson, Robert Swanson, Larissa Rakhilina et al. · Cell · 1998 · 199 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +11

A reevaluation of the spleen tyrosine kinase (SYK) activation mechanism

My Sam Mansueto, Abigail L. Reens, Larissa Rakhilina et al. · Journal of Biological Chemistry · 2019 · 59 citations · Full text

Life Sciences, Immunology, Molecular Biology +11

Functional Expression of Heteromeric Calcitonin Gene-related Peptide and Adrenomedullin Receptors in Yeast

Juan J. Miret, Larissa Rakhilina, L. B. Silverman et al. · Journal of Biological Chemistry · 2002 · 46 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Identification of N-(1H-pyrazol-4-yl)carboxamide inhibitors of interleukin-1 receptor associated kinase 4: Bicyclic core modifications

Jongwon Lim, Michael D. Altman, James Α. Baker et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 32 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

1–5 of 7